When the biodefense ‘experts’ at Johns Hopkins warn you off the ACAM-2000 vaccine for monkeypox, you know it is a really bad vaccine. But they still don’t tell you the whole story, Dr. Meryl Nass wrote yesterday.
On 9 August, STAT News reported that the US health secretary recently declared monkeypox as a public health emergency, paving the way for emergency use authorisations of additional vaccines or vaccine regimens to fight the disease.
But this strategy could also backfire, STAT News noted: “If there is a risk to effectiveness, it may be better to focus the available full doses of vaccine on individuals at highest risk – men who have sex with multiple male partners.”
Further reading: Smallpox Vaccines for Monkeypox Are in Short Supply Until 2023
Two days later, on 11 August, STAT reported that as the US grapples with monkeypox one of the key strategies that will be used to control its spread is vaccinating high-risk individuals.
Read More: Monkeypox vaccine shortage is a scam, says Dr. Meryl Nass
